Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5536 to 5550 of 7707 results

  1. Further research into whether concomitant dacarbazine enhances the clinical effectiveness of ipilimumab would be encouraged because it could provide information for future treatment strategies, as would more data on the relative effectiveness of ipilimumab when given as a first-line or second-line treatment.

    Recommendation ID TA319/2 Question Further research into whether concomitant dacarbazine enhances the clinical effectiveness of ipilimumab

    Research recommendation
    Published
    9 June 2015

  2. Further research into the analytical and clinical validity of the enzyme-linked immunosorbent assay (ELISA) kits (LISA-TRACKER, IDKmonitor and Promonitor) is recommended, specifically on:- the best methods to measure tumour necrosis factor (TNF)-alpha-inhibitor levels in the presence of antibodies to TNF-alpha inhibitors- developing primary reference standards- the accuracy for predicting clinical state- clinically meaningful thresholds.

    Recommendation ID DG22/1 Question Further research into the analytical and clinical validity of the enzyme-linked immunosorbent assay (ELISA)

    Research recommendation
    Published
    21 March 2016

  3. Further research into whether ticagrelor is particularly beneficial in any clinical or biological subgroups would be useful.

    Recommendation ID TA236/2 Question Further research into whether ticagrelor is particularly beneficial in any clinical or biological subgroups

    Research recommendation
    Published
    9 June 2015

  4. Further research into the comparative efficacy and safety of different surgical and ablative treatments would be useful.

    Recommendation ID IPG405/1 Question Further research into the comparative efficacy and safety of different surgical and ablative treatments

    Research recommendation
    Published
    9 June 2015

  5. Further research is needed on the benefits and consequences of detecting preclinical diabetic peripheral neuropathy.

    Recommendation ID MTG38/1 Question Further research is needed on the benefits and consequences of detecting preclinical diabetic peripheral

    Research recommendation
    Published
    3 January 2019

  6. In its evaluation of burosumab, the committee noted substantial uncertainty in several areas, and agreed that further research into the treatment benefit of burosumab in young people aged 13 years and over would relieve some of the clinical uncertainty in an age group covered by the marketing authorisation.

    Recommendation ID HST8/1 Question In its evaluation of burosumab, the committee noted substantial uncertainty in several areas, and agreed

    Research recommendation
    Published
    22 March 2019

  7. Further research is needed on the impact of faecal calprotectin testing on clinical decision-making when added to current practice. This includes research into optimal cut-off values for tests and the investigation of repeat testing strategies in people with intermediate levels of faecal calprotectin. Development of a consistent definition for the 'intermediate range' is encouraged.

    Recommendation ID DG11/2 Question Further research is needed on the impact of faecal calprotectin testing on clinical decision-making when

    Research recommendation
    Published
    9 June 2015

  8. Further research is needed on the use and clinical utility of faecal calprotectin testing, and support pathways for the long-term management of these conditions in the community should be developed.

    Recommendation ID DG11/1 Question Further research is needed on the use and clinical utility of faecal calprotectin testing, and support

    Research recommendation
    Published
    9 June 2015

  9. Further research is needed to understand the effect of having the additional information provided by the adjunctive colposcopy technologies on anxiety for people having a colposcopy, when this information is shown to a person during the examination.

    Recommendation ID DG32/3 Question Further research is needed to understand the effect of having the additional information provided by

    Research recommendation
    Published
    21 November 2018

  10. Risk assessment: From the perspective of everyone involved, what works well and could be improved about the use of tools and checklists to support social work risk assessment for people with complex needs?

    Recommendation ID NG216/02 Question Risk assessment: From the perspective of everyone involved, what works well and could be improved about

    Research recommendation
    Published
    1 June 2022

  11. In infants, children and young people with overt or occult reflux, is fundoplication effective in reducing acid reflux as determined by oesophageal pH monitoring?

    Recommendation ID NG1/3 Question In infants, children and young people with overt or occult reflux, is fundoplication effective in reducing

    Research recommendation
    Published
    15 November 2019

  12. Further collection of quality of life data from people who are cured and who have experience of amputation and chemotherapy are also needed. Additional data on the health effects on parents, siblings and others with life-threatening illness would also be of value.

    Recommendation ID TA235/2 Question Further collection of quality of life data from people who are cured and who have experience of amputation

    Research recommendation
    Published
    9 June 2015

  13. Further data collection and research are recommended to assess clinical outcomes after positive and negative SeHCAT test results. This research should focus on clinical outcomes relevant to people with chronic diarrhoea, such as severity of symptoms, including urgency. Clinical outcomes should be measured in the short and long term.

    Recommendation ID DG44/02 Question Further data collection and research are recommended to assess clinical outcomes after positive and

    Research recommendation
    Published
    16 December 2021

  14. Further data collection and research are recommended to assess the effectiveness of treatment options for bile acid diarrhoea. Consideration should be given to how well the treatments are tolerated and how they affect the severity of symptoms in the longer term.

    Recommendation ID DG44/03 Question Further data collection and research are recommended to assess the effectiveness of treatment options

    Research recommendation
    Published
    16 December 2021

  15. Further data collection and research are recommended to better understand the health-related quality of life in people with bile acid diarrhoea. Consideration should be given to how quality of life differs before and after a positive or negative test and diagnosis, and how it is affected by treatment and symptom severity.

    Recommendation ID DG44/04 Question Further data collection and research are recommended to better understand the health-related quality

    Research recommendation
    Published
    16 December 2021